CERo Therapeutics Stock (NASDAQ:CEROW)
Previous Close
$0.02
52W Range
$0.01 - $0.02
50D Avg
-
200D Avg
-
Market Cap
$1.10M
Avg Vol (3M)
-
Beta
-0.46
Div Yield
-
CEROW Company Profile
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.